Alle Storys
Folgen
Keine Story von SYGNIS AG mehr verpassen.

SYGNIS AG

euro adhoc: Sygnis Pharma AG
Interim Announcement
Announcement according to articles 37v ff. WpHG [Securities Trading Act] with the aim of a Europe-wide distribution

Announcement on Publication of Financial Reports
SYGNIS Pharma AG announces today that the following financial reports will be
published in the Fiscal Year 2007/2008:
1. Consolidated interim financial statement as of June 30th,
2007("3-Months-Report") will be released on August 14th, 2007
2. Consolidated interim financial statement as of September 30th, 2007
("Half-Year-Report") will be released on November 13th, 2007
3. Consolidated interim financial statement as of December 31st, 2007
("Nine-Months-Report") will be released on February 12th, 2008
Each report will be published on the Website of SYGNIS Pharma AG.
  Tip announcement for financial statements transmitted by euro adhoc. The
  issuer is responsible for the content of this announcement.
Company data:
additional (optional) statements: Contact:
Dr. Franz-Werner Haas
VP Operations, General Counsel
Tel.: +49 06221 454 812 
investors@sygnis.de
The financial statement is available:
in the internet at: http://www.sygnis.de/investor_relations/financial_reports/fy_2008
in the internet on:    14.08.2007
additional statements: Date of publication of the announcement is July 12th, 2007.
end of announcement                               euro adhoc 12.07.2007 17:44:26

Further inquiry note:

Branche: Biotechnology
ISIN: DE0005043509
WKN: 504350
Index: CDAX
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade

Weitere Storys: SYGNIS AG
Weitere Storys: SYGNIS AG